StonvexLoading…
StonvexStonvexStonvexCore line items from SNWV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $30.86M | $19.44M | $9.29M | $32.33M |
Operating Income | $2.94M | $2.04M | $601.00K | $3.85M |
Net Income | $4.12M | $-5.57M | $-6.12M | $-33.08M |
EPS (Diluted) | $0.21 | $-0.65 | $-0.72 | $-7.41 |
Total Assets | $35.60M | $33.05M | $30.86M | $30.12M |
Total Liabilities | $43.19M | $51.84M | $51.67M | $45.91M |
Cash & Equivalents | $9.60M | $8.50M | $8.50M | $10.24M |
Free Cash Flow OCF − CapEx | $-1.29M | $-1.84M | $-1.68M | $1.97M |
Shares Outstanding | 8.58M | 8.57M | 8.55M | 8.54M |